Matthew Maxwell Donley, Chief Operating Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 183,884 shares at $8.00 ($1.5M) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($1.5M) by Chief Operating Officer — this insider has traded AUPH in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 65,902 | $527K | 36.1% |
| 2 | $7.92 | 58,991 | $467K | 32.0% |
| 3 | $7.92 | 58,991 | $467K | 32.0% |
| Total | $7.95 avg | 183,884 | $1.5M | 100% |
| Filing → |
| AUPH | SELL | 2022-03-04 | $37K | — | Filing → |
| AUPH | BUY | 2021-05-12 | $100K | — | Filing → |